Thong Y H, Ferrante A
Aust N Z J Med. 1978 Dec;8(6):620-2. doi: 10.1111/j.1445-5994.1978.tb04850.x.
Activation of the alternative pathway of complement by Candida albicans was examined using a chemotactic assay. Two serologically defined strains and eight clinical isolates of Candida albicans were used in these experiments. The results showed that all ten strains of Candida albicans were capable of alternative complement pathway activation. These findings may provide an insight into host resistance to this infection.